Humacyte
Price & Volume
Stats
See moreOpen | $4.35 |
Previous Close | $4.38 |
Day Range | $4.34-$4.52 |
52W Range | $2.43-$9.97 |
Market Cap | $567.4M |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $1.5M |
Diluted EPS | -$1.34 |
News
See moreYahoo Finance • 7 months ago
10 Stocks American Politicians are Buying in 2024
Yahoo Finance • 12 months ago
Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference
Yahoo Finance • last year
Humacyte Announces Two Presentations at the VEITHsymposium® of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Trauma
Yahoo Finance • last year
Humacyte Third Quarter 2023 Financial Results and Business Update
About
CEO | Dr. Laura E. Niklason M.D., Ph.D. |
CFO | Mr. Dale A. Sander |
Address | 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 183 |
